Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
FACTX vs HRTS
Shared holdings
22
FACTX covered by HRTS
35.55%
HRTS covered by FACTX
35.55%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
FACTX (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| BOSTON SCIENTIFIC CORP | 6.92% | |
| LILLY ELI and CO | 6.25% | |
| DANAHER CORP | 6.06% | |
| JOHNSON&JOHNSON | 3.49% | |
| Fidelity Securities Lending Cash Central Fund | 3.03% | |
| ABBVIE INC | 2.93% | |
| ARGENX SE SPONSORED ADR | 2.73% | |
| UCB SA | 2.53% | |
| Ascendis Pharma A/S | 2.50% | |
| CVS HEALTH CORP | 2.11% | |
| MASIMO CORP | 2.05% | |
| EDWARDS LIFESCIENCES CORP | 2.01% | |
| VEEVA SYSTEMS-A | 1.87% | |
| THERMO FISHER SCIENTIFIC INC | 1.86% | |
| ALNYLAM PHARMACEUTICALS INC | 1.68% | |
| GILEAD SCIENCES INC | 1.65% | |
| UNITEDHEALTH GRP | 1.54% | |
| MERCK & CO | 1.51% | |
| VIRIDIAN THERAPEUTICS INC | 1.48% | |
| COGENT BIOSCIENCES INC | 1.46% | |
| PENUMBRA INC | 1.39% | |
| MODERNA INC | 1.34% | |
| INSULET CORP | 1.33% | |
| IQVIA HOLDINGS INC | 1.28% | |
| BRIGHTSPRING HEALTH SERVICES INC | 1.27% | |
| NUVALENT INC-A | 1.23% | |
| INSMED INC | 1.17% | |
| LEGEND BIOTECH CORP SPON ADR | 1.07% | |
| CRINETICS PHARMACEUTICALS INC | 1.03% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 1.02% | |
| WAYSTAR HOLDING CORP | 1.01% | |
| MCKESSON CORP | 0.99% | |
| CARIS LIFE SCIENCES INC | 0.98% | |
| ROYALTY PHARMA PLC | 0.94% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.92% | |
| VAXCYTE INC | 0.89% | |
| REPLIGEN CORP | 0.89% | |
| STRYKER CORP | 0.88% | |
| XENON PHARMACEUTICALS INC | 0.84% | |
| DISC MEDICINE INC | 0.84% | |
| PRIVIA HEALTH GROUP INC | 0.82% | |
| INTUITIVE SURGICAL INC | 0.79% | |
| PRAXIS PRECISION MEDICINES INC | 0.77% | |
| ALIGNMENT HEALTHCARE INC | 0.75% | |
| MEDLINE INC-A | 0.74% | |
| BIONTECH SE ADR | 0.71% | |
| CG ONCOLOGY INC | 0.66% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 0.62% | |
| ORUKA THERAPEUTICS INC | 0.61% | |
| 10X GENOMICS INC | 0.60% |
HRTS (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 10.02% | |
| Roche Holding AG | 5.47% | |
| JOHNSON&JOHNSON | 4.86% | |
| ASTRAZENECA PLC | 4.82% | |
| MERCK & CO | 4.24% | |
| THERMO FISHER SCIENTIFIC INC | 3.90% | |
| UNITEDHEALTH GRP | 3.85% | |
| GILEAD SCIENCES INC | 3.62% | |
| Novartis AG (Registered) | 3.62% | |
| ABBOTT LABS | 3.37% | |
| VERTEX PHARMACEUTICALS INC | 3.21% | |
| ABBVIE INC | 2.96% | |
| DANAHER CORP | 2.92% | |
| BOSTON SCIENTIFIC CORP | 2.47% | |
| MEDTRONIC PLC | 2.37% | |
| BRIDGEBIO PHARMA INC | 2.23% | |
| REVOLUTION MEDICINES INC | 2.22% | |
| BRISTOL-MYERS SQUIBB CO | 2.17% | |
| MCKESSON CORP | 2.16% | |
| NOVO NORDISK-B | 2.15% | |
| AMGEN INC | 2.10% | |
| CHUGAI PHARMA CO | 2.06% | |
| REGENERON PHARMACEUTICALS INC | 2.02% | |
| EDWARDS LIFESCIENCES CORP | 1.86% | |
| TEVA PHARMACEUTICAL IND ADR | 1.62% | |
| CYTOKINETICS INC | 1.48% | |
| INTUITIVE SURGICAL INC | 1.47% | |
| MASIMO CORP | 1.36% | |
| DEXCOM INC | 1.29% | |
| MADRIGAL PHARMACEUTICALS INC | 1.21% | |
| INSMED INC | 1.19% | |
| ALNYLAM PHARMACEUTICALS INC | 1.19% | |
| INSULET CORP | 1.04% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.03% | |
| VIKING THERAPEUTICS INC | 0.85% | |
| IONIS PHARMACEUTICALS INC | 0.83% | |
| SCHOLAR ROCK HOLDING CORP | 0.78% | |
| Ascendis Pharma A/S | 0.75% | |
| CRINETICS PHARMACEUTICALS INC | 0.64% | |
| FIRST AM-TR OB-X | 0.59% | |
| NEUROCRINE BIOSCIENCES INC | 0.57% | |
| ZEALAND PHARMA A | 0.56% | |
| GUBRA A/S | 0.51% | |
| INTELLIA THERAPEUTICS INC | 0.35% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.